Search research articles
Contact Us
Filters
Showing results (101-110 of 212) with videos related to
Page
of 22
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology
|
August 27, 2016
GLP-1-Based Therapies Have No Microvascular Effects in Type 2 Diabetes Mellitus: An Acute and 12-Week Randomized, Double-Blind, Placebo-Controlled Trial
Mark M Smits, Lennart Tonneijck, Marcel H A Muskiet, et al.
BMC Endocrine Disorders
|
August 22, 2015
Design and rationale of the IN CONTROL trial: the effects of real-time continuous glucose monitoring on glycemia and quality of life in patients with type 1 diabetes mellitus and impaired awareness of hypoglycemia
Cornelis A J van Beers, Susanne J Kleijer, Erik H Serné, et al.
Diabetologia
|
January 14, 2015
Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes
Silvio E Inzucchi, Richard M Bergenstal, John B Buse, et al.
Nutrients
|
March 18, 2016
Altered Skeletal Muscle Fatty Acid Handling in Subjects with Impaired Glucose Tolerance as Compared to Impaired Fasting Glucose
Gijs H Goossens, Chantalle C M Moors, Johan W E Jocken, et al.
Diabetes Care
|
April 21, 2012
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Silvio E Inzucchi, Richard M Bergenstal, John B Buse, et al.
European Journal of Endocrinology
|
December 4, 2013
Does dipeptidyl peptidase-4 inhibition prevent the diabetogenic effects of glucocorticoids in men with the metabolic syndrome? A randomized controlled trial
Renate E van Genugten, Daniël H van Raalte, Marcel H Muskiet, et al.
European Journal of Pediatrics
|
October 21, 2010
Differential impact of impaired fasting glucose versus impaired glucose tolerance on cardiometabolic risk factors in multi-ethnic overweight/obese children
Mariska van Vliet, Roel P Gazendam, Inès A von Rosenstiel, et al.
Clinical Biochemistry
|
February 27, 2010
Urinary matrix metalloproteinase-8 and -9 activities in type 2 diabetic subjects: A marker of incipient diabetic nephropathy?
Nynke J van der Zijl, Roeland Hanemaaijer, Maarten E Tushuizen, et al.
The American Journal of Cardiology
|
October 31, 2013
Effect of type 2 diabetes mellitus on epicardial adipose tissue volume and coronary vasomotor function
Weena J Y Chen, Ibrahim Danad, Pieter G Raijmakers, et al.
Diabetes
|
July 9, 2009
Functional brain connectivity and neurocognitive functioning in patients with long-standing type 1 diabetes with and without microvascular complications: a magnetoencephalography study
Eelco van Duinkerken, Martin Klein, Niki S M Schoonenboom, et al.
Page
of 22
Search research articles
Search
Showing results (101-110 of 212) with videos related to
Sort By:
Page
of 22
Arteriosclerosis, Thrombosis, and Vascular Biology
|
August 27, 2016
GLP-1-Based Therapies Have No Microvascular Effects in Type 2 Diabetes Mellitus: An Acute and 12-Week Randomized, Double-Blind, Placebo-Controlled Trial
Mark M Smits, Lennart Tonneijck, Marcel H A Muskiet, et al.
BMC Endocrine Disorders
|
August 22, 2015
Design and rationale of the IN CONTROL trial: the effects of real-time continuous glucose monitoring on glycemia and quality of life in patients with type 1 diabetes mellitus and impaired awareness of hypoglycemia
Cornelis A J van Beers, Susanne J Kleijer, Erik H Serné, et al.
Diabetologia
|
January 14, 2015
Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes
Silvio E Inzucchi, Richard M Bergenstal, John B Buse, et al.
Nutrients
|
March 18, 2016
Altered Skeletal Muscle Fatty Acid Handling in Subjects with Impaired Glucose Tolerance as Compared to Impaired Fasting Glucose
Gijs H Goossens, Chantalle C M Moors, Johan W E Jocken, et al.
Diabetes Care
|
April 21, 2012
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Silvio E Inzucchi, Richard M Bergenstal, John B Buse, et al.
European Journal of Endocrinology
|
December 4, 2013
Does dipeptidyl peptidase-4 inhibition prevent the diabetogenic effects of glucocorticoids in men with the metabolic syndrome? A randomized controlled trial
Renate E van Genugten, Daniël H van Raalte, Marcel H Muskiet, et al.
European Journal of Pediatrics
|
October 21, 2010
Differential impact of impaired fasting glucose versus impaired glucose tolerance on cardiometabolic risk factors in multi-ethnic overweight/obese children
Mariska van Vliet, Roel P Gazendam, Inès A von Rosenstiel, et al.
Clinical Biochemistry
|
February 27, 2010
Urinary matrix metalloproteinase-8 and -9 activities in type 2 diabetic subjects: A marker of incipient diabetic nephropathy?
Nynke J van der Zijl, Roeland Hanemaaijer, Maarten E Tushuizen, et al.
The American Journal of Cardiology
|
October 31, 2013
Effect of type 2 diabetes mellitus on epicardial adipose tissue volume and coronary vasomotor function
Weena J Y Chen, Ibrahim Danad, Pieter G Raijmakers, et al.
Diabetes
|
July 9, 2009
Functional brain connectivity and neurocognitive functioning in patients with long-standing type 1 diabetes with and without microvascular complications: a magnetoencephalography study
Eelco van Duinkerken, Martin Klein, Niki S M Schoonenboom, et al.
Page
of 22